45 results
424B5
MRK
Merck & Co Inc
10 May 23
Prospectus supplement for primary offering
4:27pm
pandemic. One must carefully consider any such statement and should understand that many factors could cause actual results to differ materially from our … of the global COVID-19 pandemic and any future pandemic, epidemic, or similar public health threat, on the Company’s business, operations, financial
424B5
wvemqcs
8 May 23
Prospectus supplement for primary offering
8:17am
PX14A6G
n4k m6s2a7ot7
21 Apr 23
Letter to shareholders
7:39pm
PX14A6G
96it32vt450ganoug8r
19 Apr 23
Letter to shareholders
4:04pm
8-K
EX-99.1
bpipxpnh97lo90pt
27 Oct 22
Merck Announces Third-Quarter 2022 Financial Results
6:38am
8-K
EX-99.1
ewzu j0ukw
28 Jul 22
Merck Announces Second-Quarter 2022 Financial Results
6:36am
PX14A6G
qw3v4u2alr ahik7yz
13 May 22
Letter to shareholders
2:32pm
8-K
EX-99.1
eerv7mb2eo19w8
28 Apr 22
Merck Announces First-Quarter 2022 Financial Results
6:35am
424B5
ts8zoiodqecm
9 Dec 21
Prospectus supplement for primary offering
4:37pm